 reported 500 patients who underwent RFA, and 13 (2.6%)
experienced thrombus bulging into the femoral vein or
adherent to its wall, which was treated with low-molecularweight heparin. All of these patients had thrombus retraction to the level of the SFJ in an average of 16 days. A
significantly higher rate of proximal thrombus extension
was noted in those patients with a history of D